4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000061
Chief Operating Officer sold 600 shares at $69.69 ($41,814)
From the SEC's structured data for this filing
Trades in this filing
Sandler Laura Lee · Chief Operating Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Sale : show line 1 in the form | −600 | $69.69 | $41,814 | 236,384 | D |
| Open-market sales · 600 sh · avg $69.69 · $41,814 | ||||||
Loading xslF345X06/form4.xml…